A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathways
- Luoqi Jia†1,
- Hongyan Jin†1,
- Jiayi Zhou1,
- Lianghua Chen2,
- Yiling Lu3,
- Yanlin Ming2 and
- Yinhua Yu1Email author
© Jia et al; licensee BioMed Central Ltd. 2013
Received: 12 June 2012
Accepted: 11 February 2013
Published: 15 February 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|12 Jun 2012||Submitted||Original manuscript|
|1 Sep 2012||Reviewed||Reviewer Report - Devarajan Karunagaran|
|19 Oct 2012||Reviewed||Reviewer Report - Linda Einbond|
|6 Dec 2012||Author responded||Author comments - Yinhua Yu|
|Resubmission - Version 2|
|6 Dec 2012||Submitted||Manuscript version 2|
|26 Dec 2012||Reviewed||Reviewer Report - Linda Einbond|
|11 Jan 2013||Reviewed||Reviewer Report - Devarajan Karunagaran|
|2 Feb 2013||Author responded||Author comments - Yinhua Yu|
|Resubmission - Version 3|
|2 Feb 2013||Submitted||Manuscript version 3|
|11 Feb 2013||Editorially accepted|
|15 Feb 2013||Article published||10.1186/1472-6882-13-33|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.